Bausch Health
BHC
₹534.92
Share price
0.00%
Change (1 day)
-4.93%
Change (1 year)
Categories
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.
Earnings for Bausch Health (BHC)
Earnings in 2025 (TTM): ₹16.15 Billion
According to Bausch Health 's latest financial reports the company's current earnings are ₹9.73 Billion. In 2024 the company made an earning of ₹14.45 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Bausch Health from 1994 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | ₹16.15 B | 11.74% |
| 2024 | ₹14.45 B | |
| 2022 | -₹11.17 Billion | -87.4% |
| 2021 | -₹88.64 Billion | 9.64% |
| 2020 | -₹80.85 Billion | -49.16% |
| 2019 | -₹159.01 Billion | -55.78% |
| 2018 | -₹359.56 Billion | 138.6% |
| 2017 | -₹150.7 Billion | -28.5% |
| 2016 | -₹210.78 Billion | 1806.89% |
| 2015 | -₹11.06 Billion | -111.69% |
| 2014 | ₹94.57 B | -183.12% |
| 2013 | -₹113.78 Billion | 233.41% |
| 2012 | -₹34.13 Billion | 2090.16% |
| 2011 | -₹1.56 Billion | -92.38% |
| 2010 | -₹20.46 Billion | -235.04% |
| 2009 | ₹15.14 B | 37.86% |
| 2008 | ₹10.98 B | -39.2% |
| 2007 | ₹18.06 B | -174.56% |
| 2006 | -₹24.24 Billion | -331.49% |
| 2005 | ₹10.46 B | 92.86% |
| 2004 | ₹5.42 B | -254.51% |
| 2003 | -₹3.52 Billion | -137.13% |
| 2002 | ₹9.46 B | 6.39% |
| 2001 | ₹8.89 B | -240.25% |
| 2000 | -₹6.35 Billion | -1229.21% |
| 1999 | ₹0.56 B | -86.29% |
| 1998 | ₹4.09 B | 27.15% |
| 1997 | ₹3.21 B | 59.23% |
| 1996 | ₹2.02 B | -1329.6% |
| 1995 | -₹0.17 Billion | 850% |
| 1994 | -₹17.32 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Onconova Therapeutics ONTX | -₹1.58 Billion | -109.61% | 🇺🇸 USA |
 OPKO Health
OPK | -₹47.96 Million | -100.29% | 🇺🇸 USA |